CARTISTEM®

BIOLOGICAL2 trials

Sponsors

Medipost, Inc., Hyundai Bioland Co., Ltd.

Conditions

Chondral or Osteochondral Lesion of TalusDegeneration Articular Cartilage Knee

Phase 1

Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects

CompletedNCT01733186

Medipost, Inc.Degeneration Articular Cartilage Knee

Start: 2013-01-07End: 2017-08-29Updated: 2026-01-29

Phase 3

Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus

CompletedNCT04310215

Hyundai Bioland Co., Ltd.Chondral or Osteochondral Lesion of Talus

Start: 2020-03-03End: 2022-06-13Updated: 2022-11-29